Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands	9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Cash flows from operating activities:
Net income	$ 29,173	$ 26,238
Adjustments to reconcile net income to net cash provided by operating activities:
Loss from discontinued operations activities, net of tax	646	3,169
Gain on sale of operations, net	(2,832)	(465)
Loss on redemption of convertible notes		1,996
Asset impairments		263
Depreciation and amortization expense	15,102	15,257
Amortization of discount on notes and deferred financing costs	3,805	3,985
Bad debt expense, net of recoveries	4,101	3,429
Adjustment to contingent earnout liability	(1,152)	(1,449)
Deferred income taxes	(4,463)	(1,226)
Employee stock awards	4,433	3,943
Excess tax benefits from share based payment arrangements	(102)	(77)
Changes in assets and liabilities, net of acquisitions and divestitures:
Restricted cash	(333)	3,537
Accounts receivable, net	(20,424)	(29,617)
Other assets	3,202	3,599
Accounts payable	(901)	1,729
Income taxes payable/refundable	7,463	4,371
Accrued personnel costs and other liabilities	500	5,054
Net cash provided by continuing operations	38,218	43,736
Operating cash flows used in discontinued operations	(641)	(2,214)
Net cash provided by operating activities	37,577	41,522
Cash flows from investing activities:
Business acquisitions and contingent consideration, net of cash acquired	(25,727)	(35,358)
Purchases of client fund investments	(18,844)	(2,975)
Proceeds from the sales and maturities of client fund investments	9,167	3,115
Proceeds from sales of divested and discontinued operations	838	1,265
Net decrease in funds held for clients	17,060	10,318
Additions to property and equipment, net	(3,729)	(2,055)
Other	23	8
Net cash used in investing activities	(21,212)	(25,682)
Cash flows from financing activities:
Proceeds from bank debt	394,950	425,125
Payment of bank debt	(354,250)	(416,125)
Proceeds from issuance of convertible notes		130,000
Repurchase of convertible notes	(39,250)	(60,000)
Payment for acquisition of treasury stock	(7,987)	(86,094)
Net decrease in client funds obligations	(9,811)	(10,458)
Proceeds from exercise of stock options	768	1,182
Payment of contingent consideration of acquisitions	(330)
Excess tax benefit from exercise of stock awards	102	77
Debt issuance costs	(599)	(6,068)
Other	(149)	(126)
Net cash used in financing activities	(16,556)	(22,487)
Net decrease in cash and cash equivalents	(191)	(6,647)
Cash and cash equivalents at beginning of year	724	7,178
Cash and cash equivalents at end of period	$ 533	$ 531